Call for Abstract

8th Euro Global Summit on Cancer Therapy, will be organized around the theme “Emerging & Innovative approaches for the advancement of cancer therapy”

Eurocancersummit-2015 is comprised of 7 tracks and 68 sessions designed to offer comprehensive sessions that address current issues in Eurocancersummit-2015.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Molecular and Cellular Oncology
  • Track 1-2Cancer Genomics and Systems Biology
  • Track 1-3tumor immunology and immune therapy
  • Track 1-4Cancer stem cells
  • Track 1-5Case study
  • Track 2-1Breast cancer
  • Track 2-2Pancreatic Cancer
  • Track 2-3Rectal Cancer
  • Track 2-4Salivary Gland Cancer
  • Track 2-5Throat Cancer
  • Track 2-6Urethral Cancer
  • Track 2-7Vulvar Cancer
  • Track 2-8Wilms Tumor
  • Track 2-9Skin Cancer
  • Track 2-10Penile Cancer
  • Track 2-11Oropharyngeal Cancer
  • Track 2-12Lip and Oral Cavity Cancer
  • Track 2-13Head and Neck Cancer
  • Track 2-14Fallopian Tube Cancer
  • Track 2-15Colon Cancer
  • Track 2-16Cervical Cancer
  • Track 2-17Kidney cancer
  • Track 2-18Blood cancer
  • Track 2-19Bone cancer
  • Track 2-20Gastrointestinal cancer
  • Track 2-21lung cancer
  • Track 2-22Liver cancer
  • Track 2-23Prostate cancer
  • Track 2-24Ovarian cancer
  • Track 2-25Colorectal cancer
  • Track 2-26Thyroid cancer
  • Track 2-27Lung cancer
  • Track 2-28Leukaemia cancer
  • Track 2-29Appendix Cancer
  • Track 2-30Appendix Cancer
  • Track 3-1Biomarkers in cancer detection
  • Track 3-2Targeting Protein involving DNA
  • Track 3-3Stem cell research
  • Track 3-4Cancer Epidemiology
  • Track 4-1Functional genomics in drug discovery & development
  • Track 4-2Therapeutic antibodies & cancer vaccines
  • Track 4-3Novel drug delivery system & cancer drug designing
  • Track 4-4Nanotechnology in cancer drugs
  • Track 4-5Anticancer drugs in global market: economy & their cost effectiveness
  • Track 4-6Cancer clinical trails
  • Track 4-7Regulatory issues in cancer research
  • Track 5-1Molecular cancer therapeutics
  • Track 5-2Clinical and potential applications of metabolomics in oncology
  • Track 5-3Metabolomics in novel biomarker discovery
  • Track 5-4Revisiting tumor metabolism
  • Track 5-5Telomerase: A target for cancer therapeutics
  • Track 5-6Analytical and bio-analytical techniques in metabolomics
  • Track 5-7Transcriptomics
  • Track 5-8Toxicology and drug metabolism
  • Track 6-1Cancer: Gene expression and protein profiling; Surgery and laparoscopy
  • Track 6-2Radiotherapy and chemotherapy
  • Track 6-3Hormone replacement therapy
  • Track 6-4Molecular-targeted therapies
  • Track 6-5Clinical medicine and targeting anti cancer drugs
  • Track 6-6Therapeutic targets in cancer
  • Track 6-7Clinical research in cancer immunology
  • Track 6-8cancer metabolism
  • Track 7-1Cancer biomarkers, Diagnostic and Prognostic Cancer Biomarkers
  • Track 7-2Metabolomics in novel biomarker discovery
  • Track 7-3Clinical and prospective applications of metabolomics in oncology
  • Track 7-4Analytical and Bio-Analytical Techniques in Metabolomics
  • Track 7-5Current Trends and Innovations in Metabolomics
  • Track 7-6Metabolomics Syndrome